INDIANAPOLIS - The Indiana Biosciences Research Institute announced today a gift of $100 million in grants to grow Indiana’s bioscience sector. The money aims to address metabolic disease – like obesity, high blood pressure and diabetes.
The Lilly Endowment and Eli Lilly and Company Foundation are donating the money that includes matching grants to the nonprofit Indiana Biosciences Research Institute in Indianapolis. This grant brings IBRI halfway to its $350 million goal.
IBRI aims to build a new building, hire more than 100 top researchers and advance the life science industry in Indiana.
About half a million Hoosiers have diabetes, 65 percent of Indiana’s adults are overweight and over a third have high blood pressure.
IBRI President and CEO, David Broecker says the institute aims to improve research internationally and fight a growing epidemic in Indiana.
"Unfortunately we’re at the bottom of the table when it comes to diabetes rates, obesity rates and high blood pressure," Broecker said.
IBRI was founded in 2013 to focus on metabolic disease and poor nutrition. They hope to break ground on their new building later this year.